CovidChloroV1, Main, Corpus, bibRecord, 001989

Does hydroxychloroquine combat COVID-19? A timeline of evidence.

Identifieur interne : 001989 ( Main/Corpus ); précédent : 001988; suivant : 001990

Does hydroxychloroquine combat COVID-19? A timeline of evidence.

Auteurs : Erisa Alia ; Jane M. Grant-Kels

Source :

Journal of the American Academy of Dermatology [ 1097-6787 ] ; 2020.

RBID : pubmed:32283236

English descriptors

KwdEn :
- Betacoronavirus (isolation & purification), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Coronavirus Infections (virology), Drug Approval (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), Pneumonia, Viral (virology), Randomized Controlled Trials as Topic (MeSH), SARS-CoV-2 (MeSH), Time Factors (MeSH), United States (MeSH), United States Food and Drug Administration (legislation & jurisprudence).
MESH :
- chemical , therapeutic use : Hydroxychloroquine.
- geographic : United States.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- isolation & purification : Betacoronavirus.
- legislation & jurisprudence : United States Food and Drug Administration.
- virology : Coronavirus Infections, Pneumonia, Viral.
- COVID-19, Drug Approval, Humans, Pandemics, Randomized Controlled Trials as Topic, SARS-CoV-2, Time Factors.

DOI: 10.1016/j.jaad.2020.04.031
PubMed: 32283236
PubMed Central: PMC7151328

Links to Exploration step

pubmed:32283236

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does hydroxychloroquine combat COVID-19? A timeline of evidence.</title>
<author><name sortKey="Alia, Erisa" sort="Alia, Erisa" uniqKey="Alia E" first="Erisa" last="Alia">Erisa Alia</name>
<affiliation><nlm:affiliation>Dermatology Department, University of Connecticut, Farmington, Connecticut.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Grant Kels, Jane M" sort="Grant Kels, Jane M" uniqKey="Grant Kels J" first="Jane M" last="Grant-Kels">Jane M. Grant-Kels</name>
<affiliation><nlm:affiliation>Dermatology Department, University of Connecticut, Farmington, Connecticut. Electronic address: grant@uchc.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32283236</idno>
<idno type="pmid">32283236</idno>
<idno type="doi">10.1016/j.jaad.2020.04.031</idno>
<idno type="pmc">PMC7151328</idno>
<idno type="wicri:Area/Main/Corpus">001989</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001989</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Does hydroxychloroquine combat COVID-19? A timeline of evidence.</title>
<author><name sortKey="Alia, Erisa" sort="Alia, Erisa" uniqKey="Alia E" first="Erisa" last="Alia">Erisa Alia</name>
<affiliation><nlm:affiliation>Dermatology Department, University of Connecticut, Farmington, Connecticut.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Grant Kels, Jane M" sort="Grant Kels, Jane M" uniqKey="Grant Kels J" first="Jane M" last="Grant-Kels">Jane M. Grant-Kels</name>
<affiliation><nlm:affiliation>Dermatology Department, University of Connecticut, Farmington, Connecticut. Electronic address: grant@uchc.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of the American Academy of Dermatology</title>
<idno type="eISSN">1097-6787</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (isolation & purification)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (virology)</term>
<term>Drug Approval (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Randomized Controlled Trials as Topic (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Time Factors (MeSH)</term>
<term>United States (MeSH)</term>
<term>United States Food and Drug Administration (legislation & jurisprudence)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>United States Food and Drug Administration</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Drug Approval</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Randomized Controlled Trials as Topic</term>
<term>SARS-CoV-2</term>
<term>Time Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32283236</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6787</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>83</Volume>
<Issue>1</Issue>
<PubDate><Year>2020</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the American Academy of Dermatology</Title>
<ISOAbbreviation>J Am Acad Dermatol</ISOAbbreviation>
</Journal>
<ArticleTitle>Does hydroxychloroquine combat COVID-19? A timeline of evidence.</ArticleTitle>
<Pagination><MedlinePgn>e33-e34</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0190-9622(20)30607-1</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaad.2020.04.031</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alia</LastName>
<ForeName>Erisa</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Dermatology Department, University of Connecticut, Farmington, Connecticut.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Grant-Kels</LastName>
<ForeName>Jane M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>Dermatology Department, University of Connecticut, Farmington, Connecticut. Electronic address: grant@uchc.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Am Acad Dermatol</MedlineTA>
<NlmUniqueID>7907132</NlmUniqueID>
<ISSNLinking>0190-9622</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Am Acad Dermatol. 2020 Jul;83(1):e73-e74</RefSource>
<PMID Version="1">32348818</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017277" MajorTopicYN="N">Drug Approval</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014486" MajorTopicYN="N">United States Food and Drug Administration</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>04</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32283236</ArticleId>
<ArticleId IdType="pii">S0190-9622(20)30607-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.jaad.2020.04.031</ArticleId>
<ArticleId IdType="pmc">PMC7151328</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Antimicrob Chemother. 2020 Jul 1;75(7):1667-1670</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32196083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 May;55(5):105938</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171740</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32194981</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Jun 16;172(12):819-821</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32227189</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105923</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32070753</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Apr;55(4):105932</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32145363</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Mar 23;368:m1166</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205321</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Chem. 2006 May 4;49(9):2845-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16640347</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001989 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001989 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32283236
   |texte=   Does hydroxychloroquine combat COVID-19? A timeline of evidence.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32283236" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Does hydroxychloroquine combat COVID-19? A timeline of evidence.

Does hydroxychloroquine combat COVID-19? A timeline of evidence.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki